Vaccine preparation

Paris, 30 June, 2022 – The European HIV Vaccine Alliance (EHVA) announces the start of the EHVA T02 / ANRS VRI07 trial, a phase II placebo-controlled randomised trial that will evaluate an experimental therapeutic HIV vaccine and an immunotherapy drug vedolizumab for people living with HIV. The trial is scheduled to take place at sites in France, Germany, Switzerland, and the UK. 

It is with great sadness that we mark the passing of Dr. Charles Boucher.

Please read our publishable summary at M30 of the project

Karnataka SSLC Result 2017: Karnataka Class 10th Results ...


This project has received funding from the European Union's Horizon 2020 research
and innovation programme under grant agreement N° 681032